Ohio to Resume Johnson & Johnson Vaccine Distribution

Ohio providers can now administer the Johnson & Johnson vaccine after it was halted due to some recipients developed rare blood clots.

Governor Mike DeWine released the following statement:

“Our country’s vaccine safety system has worked as designed – these extremely rare, serious blood-clotting events were reported into the CDC’s Vaccine Adverse Event Reporting System (VAERS), and the vaccine distribution was paused to allow a thorough review of the facts and time to educate healthcare providers on the rare events. Now, a comprehensive analysis by the independent medical professionals on the ACIP has resulted in the recommendation that the benefits of Johnson & Johnson vaccine outweigh the risks, and that vaccine administration resume. The CDC and FDA have accepted those recommendations, lifting the pause on the Johnson & Johnson COVID-19 vaccine. Providers in Ohio are permitted to immediately resume administering Johnson & Johnson vaccines in Ohio, provided they continue to follow all guidance by the CDC and FDA.”

Sponsored Content

Sponsored Content